南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

针对银屑病治疗中PCSK9–PR–IL-17轴的靶向作用

Targeting the PCSK9–PR–IL-17 axis for psoriasis therapy

Yan Li, Yingxue He, Shengwei He, Zirun Yin, Kai Huang, Chenyang Jiao, Yugui Xia, Qiong Luo, Chao Luan, Wenjie Guo

Journal:Frontiers in Pharmacology

IF:5.4

DOI:10.3389/fphar.2026.1884619

PMID:

Published:2026-09-10

research field:分子生物学皮肤病学免疫学信号转导炎症性皮肤病代谢紊乱

Abstract

IntroductionPsoriasis is a chronic, immune-mediated inflammatory dermatosis characterized by keratinocyte hyperproliferation and systemic metabolic comorbidities. Although proprotein convertase subtilisin/kexin type 9 (PCSK9) is a well-established regulator of lipid metabolism, its role in the cutaneous inflammatory microenvironment remains poorly defined. This study investigated the contribution of PCSK9 to psoriatic inflammation and its potential underlying mechanisms.MethodsPCSK9 expression was assessed in human psoriatic lesions and an imiquimod (IMQ)-induced mouse model. The effects of pharmacological PCSK9 inhibition with SBC-110736 were evaluated using PASI-like scores and inflammatory cell infiltration. Transcriptomic analysis was performed to identify associated signaling pathways. The relationship between PCSK9 and progesterone receptor (PR) expression in keratinocytes and the effects of the PR agonist progesterone were also examined.ResultsPCSK9 expression was significantly upregulated in human psoriatic lesions and in the IMQ-induced mouse model. SBC-110736 attenuated psoriasis-like disease severity, reducing PASI-like scores and infiltration of CD4+ and CD11b+ cells. Transcriptomic analysis indicated that PCSK9 inhibition primarily suppressed interleukin-17 (IL-17) signaling while restoring Pgr expression. PCSK9 and PR expression were inversely associated in keratinocytes, suggesting that PCSK9-mediated PR downregulation may exacerbate IL-17-driven inflammation. Progesterone treatment produced similar therapeutic effects to those observed with PCSK9 inhibition.DiscussionThese findings suggest that a PCSK9–PR–IL-17 axis contributes to psoriasis pathogenesis, with PR potentially serving as an endogenous anti-inflammatory brake. Targeting this pathway may offer a strategy to modulate cutaneous inflammation, while its potential effects on related metabolic disturbances warrant further investigation.

本文使用的Yeasen产品

购物车
客服
转染试用